Johnson & Johnson reported $7.78B in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US $ 2469M 317M
Abbvie ABBV:US $ 6290M 282M
Abiomed ABMD:US $ -9.35M 82.84M
Bayer BAYN:GR € 1537M 1825M
Becton, Dickinson and BDX:US $ 1023M 108M
Boston Scientific BSX:US $ 665M 93M
Cardiovascular Systems CSII:US $ -5.22M 2.63M
Eli Lilly And LLY:US $ 1988.6M 80.6M
GlaxoSmithKline GSK:LN 1482M 225M
Hill Rom HRC:US $ 116.6M 28.4M
Insulet PODD:US $ -28.4M 28.7M
Intuitive Surgical ISRG:US $ 644.9M 99.9M
Johnson & Johnson JNJ:US $ 7776M 515M
Merit Medical Systems MMSI:US $ 43.88M 6.37M
Novartis NOVN:VX SF 4424M 620M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sanofi SAN:FP € 2180M 376M
Teva Pharmaceutical TEVA:IT 794M 650M
Zimmer Biomet Holdings Inc ZBH:US $ 480.5M 53.3M